Features

General Pulmonology

ASH 2020 Guidelines on Venous Thromboembolism Management

The American Society of Hematology released evidence-based guidelines for the treatment of DVT and PE in patients without cancer.

Lung Infection

COVID-19 Vaccine Allocation: Ethical Concerns, Practical Challenges

In the event of a likely scarcity of COVID-19 vaccines, a framework must be developed to inform who should get priority.

Prevention

Discussing Influenza and Pneumococcal Vaccines With Patients During COVID-19

How should physicians be discussing influenza and pneumococcal vaccines with patients amidst the continuing COVID-19 pandemic?

General Pulmonology

The Potential Effects of Wildfire Smoke on COVID-19 Risk and Severity

There may be interactive health effects between the 2 crises of the COVID-19 pandemic and US wildfires.

Lung Cancer

Tepotinib Yields High Partial Response Rates in NSCLC With MET Alterations

The MET alteration occurs in 3% to 4% of patients with the condition.

Lung Infection

ACTIV-2 and Operation Warp Speed: An Interview With COVID-19 Investigator, Davey Smith, MD

Davey Smith, MD, provides insight into current and future research opportunities targeting SARS-CoV-2.

General Pulmonology

How the Coronavirus Pandemic May Affect Cancer Clinical Trials

Risks of moving clinical trials online include missing key information about the patient experience — and higher dropout rates could also impair the overall quality of trials.

Lung Infection

BCG Tuberculosis Vaccine: Potential Protection Against COVID-19

Findings suggest lower rates of COVID-19 infection and mortality in countries with universal neonatal BCG tuberculosis vaccination policies compared with countries without this practice.

Restrictive Lung Disease

Pulmonary Fibrosis Awareness Month: Spotlight on the PFF Care Center Network

As a central goal of PF Awareness Month and their ongoing work, the Pulmonary Fibrosis Foundation aims to improve diagnostic delays and misdiagnoses in this patient population.

COPD

Antiplatelet Therapy in COPD May Reduce All-Cause Mortality, Improve Quality of Life

Antiplatelet therapy may delay progression of COPD, decrease the risk for acute exacerbations, improve quality of life, and even reduce all-cause mortality.